Akèy › Dyabèt tip 1 › Virginia
Etid klinik pou Dyabèt tip 1 nan Virginia
10 etid pou Dyabèt tip 1 ap chèche patisipan nan sit nan Virginia.
Vil nan Virginia
Tèks ofisyèl etid la (Anglè)
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- University of Virginia, Charlottesville
Ap rekriteFaz 3
Laj 1 a 35 · Tout sèks · Mizajou Sep 22, 2026 · NCT07222332A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- University of Virginia, Charlottesville
Ap rekriteFaz 3
Laj 1 a 35 · Tout sèks · Mizajou Sep 22, 2026 · NCT07222137A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Uva Children's Battle Building- Site Number : 8400060, Charlottesville
Ap rekriteFaz 3
Laj 1 a 25 · Tout sèks · Mizajou Sep 14, 2026 · NCT07088068A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- VCU Medical Center, Richmond, Richmond
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- University of Virginia Health System - Pediatric Diabetes Clinic, Charlottesville
Ap rekriteFaz 2
Laj 5 a 40 · Tout sèks · Mizajou Aug 24, 2026 · NCT07187531INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- University of Virginia, Charlottesville
Ap rekriteFaz 2
Laj 6 a 17 · Tout sèks · Mizajou Aug 13, 2026 · NCT07224321Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
- University of Virginia Center for Diabetes Technology, Charlottesville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT07507708Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
- University of Virginia, Charlottesville
Ap rekriteVolontè an sante akeyi
Laj 21 a 50 · Tout sèks · Mizajou May 7, 2026 · NCT07573228Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
- University of Virginia Health System, Charlottesville
Ap rekrite
Laj 18 a 40 · Tout sèks · Mizajou Feb 25, 2026 · NCT05653518Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
- University of Virginia, Charlottesville
Ap rekriteFaz 2
Laj 18 a 45 · Tout sèks · Mizajou Feb 25, 2026 · NCT07186660Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.